Beranda › Meduloblastoma › Florida
Uji klinis Meduloblastoma di Florida
6 studi untuk Meduloblastoma mencari peserta di lokasi di Florida.
Kota di Florida
Teks studi resmi (Bahasa Inggris)
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Orlando Health Arnold Palmer Hospital for Children, Orlando
- St. Joseph's Children's Hospital, Tampa
Menerima pesertaFase 2
59 Months · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05535166Digoxin Medulloblastoma Study
- Nemours Jacksonville, Jacksonville
- University of Miami, Miami
- Johns Hopkins All Children's, St. Petersburg
- dan 1 lainnya
Menerima pesertaFase 2
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
- Nemours Children's Clinic-Jacksonville, Jacksonville
- dan 7 lainnya
Menerima pesertaFase 3
Usia 4 hingga 21 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Nicklaus Children's Hospital, Miami
Menerima pesertaFase 2
Usia 3 hingga 39 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- All Children's Hospital Johns Hopkins Medicine, St. Petersburg
- dan 1 lainnya
Menerima pesertaFase 2
Hingga usia 21 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT04696029Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
- University of Florida Health, Gainesville
Menerima pesertaFase 1
Usia 4 hingga 30 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06514898Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.